Design and development of a chitosan-based nasal powder of dimethyl fumarate-cyclodextrin binary systems aimed at nose-to-brain administration. A stability study
Open Access
- 10 May 2024
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 659, 124216
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Diagnosis and Treatment of Multiple SclerosisJAMA, 2021
- Stability indicating RP‐HPLC method for determination of dimethyl fumarate in presence of its main degradation products: Application to degradation kineticsJournal of Separation Science, 2020
- Study on the relationship between crosslinking degree and properties of TPP crosslinked chitosan nanoparticlesCarbohydrate Polymers, 2020
- Evaluation of intranasal delivery route of drug administration for brain targetingBrain Research Bulletin, 2018
- Dissociation of chitosan/tripolyphosphate complexes into separate components upon pH elevationCarbohydrate Polymers, 2018
- Dimethyl Fumarate for Treatment of Multiple Sclerosis: Mechanism of Action, Effectiveness, and Side EffectsCurrent Neurology and Neuroscience Reports, 2013
- Nasal pH in patients with chronic rhinosinusitis before and after endoscopic sinus surgeryAmerican Journal of Otolaryngology, 2013
- Dry-powder form of chitosan nanospheres containing influenza virus and adjuvants for nasal immunizationArchives of Pharmacal Research, 2013
- Intranasal Treatment of Central Nervous System Dysfunction in HumansPharmaceutical Research, 2012
- Preparation of chitosan nanoparticles for encapsulation and release of proteinKorean Journal of Chemical Engineering, 2011